Company Overview
Position Overview
The HCP Non-Personal & Omnichannel Marketing Lead will lead the development of an integrated non-personal promotion, media, and omnichannel plan in support of the U.S. launch of Varegacestat. This role will play a critical part in building and optimizing a seamless, data-driven HCP experience across digital and non-personal channels to drive disease awareness, education, and brand adoption. In addition, this role will champion innovation by identifying and implementing emerging digital capabilities, including the responsible use of AI, to enhance HCP engagement, personalization, content development, and marketing effectiveness. The role requires a strategic thinker with strong digital marketing expertise, launch experience, and a deep understanding of HCP engagement in the oncology marketplace.
Responsibilities
Digital Marketing & Non-Personal Promotion
- Develop and execute data-driven HCP digital campaigns, content, and modular journeys based on time to diagnosis, specialty, prescribing behavior, and real-time engagement signals to drive disease education and product adoption
- Manage marketing automation platforms and digital engagement tools to enable personalized HCP communication
- Monitor and analyze campaign performance and engagement metrics to continuously refine targeting, creative assets, and channel mix
- Partner with media agencies to develop and optimize channel strategy, media planning and activation, ensuring precise audience targeting and efficient budget allocation
Omnichannel Strategy & Execution
- Lead the development and execution of the HCP non-personal promotion and omnichannel engagement strategy
- Design customer journeys that coordinate field promotion, digital engagement, and non-personal channels to deliver a cohesive HCP experience
- Design and implement an integrated digital ecosystem (e.g., websites, search, social, CRM, programmatic media, and paid search) that supports education, activation, and sustained engagement
Innovation & AI Enablement
- Champion the adoption of AI-driven marketing capabilities, including predictive analytics, machine learning models, and automated decisioning engines to enhance targeting, personalization, and campaign performance
- Leverage AI and advanced analytics to enable next-best-action/next-best-message frameworks, dynamic content personalization, and real-time optimization of HCP engagement
- Partner with analytics and technology teams to pilot and scale new AI-enabled marketing solutions while ensuring compliance with regulatory and data governance standards
Qualifications
- Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
- 5+ years of experience in pharmaceutical, biotech, or healthcare marketing, with a strong focus on digital, NPP, and omnichannel strategy
- Oncology launch experience required
- Proven success in digital HCP marketing (web, social, SEO/SEM, CRM, and paid media strategy) and in media planning and execution
- Strong understanding of MLR/PRC processes, claims substantiation, and OPDP regulations.
- Demonstrated ability to thrive in a fast-paced biotech environment
- Ability to travel ≥20%, including occasional weekends
Knowledge and Skills
- HCP digital and NPP expertise: Deep understanding of HCP digital engagement tactics and how to integrate channels into cohesive omnichannel journeys
- Strong analytical and problem-solving skills, with the ability to leverage market research and performance data to inform decisions and optimize impact
- Strong project management and operational execution skills; able to manage multiple workstreams and launch-critical deadlines in a fast-paced environment
- Excellent communication, storytelling, and presentation skills—able to simplify complex clinical information for varied audiences
- Experience managing agencies/vendors, budgets, and complex project plans with strong operational rigor and attention to detail
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Skills Required
- 5+ years of experience in pharmaceutical, biotech, or healthcare marketing
- Oncology launch experience
- Bachelor's degree
- Advanced degree (e.g., PharmD, MBA)
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
